Merdin, A. Et Al. 2020. Analysis of pre-chemotherapy WBC, PLT, monocyte, hemoglobin, and MPV levels in acute myeloid leukemia patients with WT1, FLT3, or NPM gene mutations. Medicine (United States) , vol.99, no.14 .

Merdin, A., Dal, M. S., Çakar, M. K., Yildiz, J., Ulu, B. U., Batgi, H., ... Tetik, A.(2020). Analysis of pre-chemotherapy WBC, PLT, monocyte, hemoglobin, and MPV levels in acute myeloid leukemia patients with WT1, FLT3, or NPM gene mutations. Medicine (United States) , vol.99, no.14.

Merdin, Alparslan Et Al. "Analysis of pre-chemotherapy WBC, PLT, monocyte, hemoglobin, and MPV levels in acute myeloid leukemia patients with WT1, FLT3, or NPM gene mutations," Medicine (United States) , vol.99, no.14, 2020

Merdin, Alparslan Et Al. "Analysis of pre-chemotherapy WBC, PLT, monocyte, hemoglobin, and MPV levels in acute myeloid leukemia patients with WT1, FLT3, or NPM gene mutations." Medicine (United States) , vol.99, no.14, 2020

Merdin, A. Et Al. (2020) . "Analysis of pre-chemotherapy WBC, PLT, monocyte, hemoglobin, and MPV levels in acute myeloid leukemia patients with WT1, FLT3, or NPM gene mutations." Medicine (United States) , vol.99, no.14.

@article{article, author={Alparslan Merdin Et Al. }, title={Analysis of pre-chemotherapy WBC, PLT, monocyte, hemoglobin, and MPV levels in acute myeloid leukemia patients with WT1, FLT3, or NPM gene mutations}, journal={Medicine (United States)}, year=2020}